Trial
NCT04006847
Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Chronic Myeloid Leukemia, Chronic Phase
Intervention
Eicosapentaenoic Acid
Why stopped
Product complaint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-01